Ad is loading...
EQNBX
Price
$22.48
Change
-$0.16 (-0.71%)
Updated
Nov 15 closing price
RMFCX
Price
$58.23
Change
-$0.50 (-0.85%)
Updated
Nov 15 closing price
Ad is loading...

EQNBX vs RMFCX

Header iconEQNBX vs RMFCX Comparison
Open Charts EQNBX vs RMFCXBanner chart's image
MFS Equity Income B
Price$22.48
Change-$0.16 (-0.71%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$58.23
Change-$0.50 (-0.85%)
VolumeN/A
CapitalizationN/A
EQNBX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EQNBX vs. RMFCX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQNBX is a StrongBuy and RMFCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. EQNBX (602M). RMFCX pays higher dividends than EQNBX: RMFCX (1.69) vs EQNBX (0.85). EQNBX was incepted earlier than RMFCX: EQNBX (12 years) vs RMFCX (22 years). EQNBX is a more actively managed with annual turnover of: 42.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than EQNBX: RMFCX (250) vs EQNBX (1000). RMFCX (21.31) and EQNBX (20.98) have marching annual gain over last year. EQNBX (46.52) and RMFCX (44.92) have equivalent 5 years return.
EQNBXRMFCXEQNBX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years22 years-
Gain YTD14.54416.44088%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets602M104B1%
Annual Yield % from dividends0.851.6950%
Returns for 1 year20.9821.3198%
Returns for 3 years7.2915.4647%
Returns for 5 years46.5244.92104%
Returns for 10 years79.4365.01122%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNTS0.630.01
+1.10%
Momentus
WWW21.79-0.24
-1.09%
Wolverine World Wide
SNAP10.60-0.16
-1.49%
Snap
SHC14.31-0.68
-4.54%
Sotera Health Company
ENTA9.53-0.60
-5.92%
Enanta Pharmaceuticals